>

WEBINARS

RSS
>

MEETINGS / EVENTS

RSS
>

FDA MEDWATCH ALERTS

RSS

May 20, 2013

All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility: Recall - Lack Of Sterility Assurance

Summary:

All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility

May 14, 2013

Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses

Summary:

Zolpidem Containing Products Drug Safety Communication

May 09, 2013

The Compounding Shop: FDA News Release - Lack of Sterility Assurance of Drug Products

Summary:

The Compounding Shop FDA News Release Lack of Sterility

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-13CE

... Read more »

Single Copies, Member Price: $360

ASA Submits Comments to CMS Regarding the CY 2011 Physician Fee Schedule Final Rule

Monday, January 03, 2011

On January 3, ASA submitted comments to CMS regarding the Physician Fee Schedule final rule for CY 2011.  ASA requested that CMS provide clarification on the methodology and calculations used to derive the 2011 anesthesia conversion factor and urged CMS to accept the AMA Relative Value Unit Committee’s (RUC) recommended work values for transforaminal epidural injections.

Please click here to view the comment letter.

« Back to Washington Alerts